Evaluation of the effectiveness and acceptability of the Bristol Medication Review toolkit

Not Applicable

• Conditions: Medication optimisation; Not Applicable

• Registration Number: ISRCTN12979016
• Lead Sponsor: niversity of Bristol

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-06-03
• Last Update Posted: 15 July 2024
• Study Completion: 2026-03-31

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 8000000

Inclusion Criteria

1. General practices using EMIS or SystmOne clinical systems, and contributing to the secure data processing environment of the nationally representative Oxford-Royal College of GPs Clinical Informatics Digital Hub (ORCHID), will be eligible to participate in the trial. All patients aged =18 years who have not registered with their practice an opt-out of sharing data outside of the practice for purposes of research or planning, will be included in the main trial analysis.
2. Within the 56 practices participating in the process evaluation, all adult patients (aged =18 years) receiving a structured medication review during four 2-week blocks within the 12-month intervention period will be sent a patient-experience questionnaire, and all adult patients receiving a review within the 12-month intervention period will be sent a quality of life questionnaire. Additionally, a smaller number of patients will be approached and invited to provide consent to participate in an interview.

Exclusion Criteria

1. Patients aged 17 years and under
2. Patients who have registered with their practice an opt-out of sharing data outside of the practice for purposes of research or planning

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Potentially inappropriate prescribing (PIP) at 12 months will be assessed using routine electronic health records.